Arkolith/Insider Trading/GPCR/Form 4

Hall Ashley

Chief Development OfficerStructure Therapeutics Inc. (GPCR) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Tax withholding(F)5K$20.99$102K107K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 20, 2025Grant(A)237—$0462
May 20, 2025Grant(A)225—$0225

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001801842-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML